Techniclone to Get $305,000 in Equity Deal
- Share via
(Dow Jones)
Techniclone Corp., a Tustin biopharmaceutical company, said Tuesday that it has received net proceeds of about $305,000 from two institutional investors under its common stock equity line subscription agreement.
The company said it will use the net proceeds, as well as cash on hand, to continue operations at reduced levels through December.
Shares of the company rose 3 cents a share Tuesday to close at 47 cents in Nasdaq SmallCap trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
